每(mei)經AI快訊，亞寶(bao)(bao)(bao)藥業（SH 600351，收(shou)(shou)盤價：6.51元）9月(yue)29日晚(wan)間發布公(gong)(gong)(gong)(gong)告稱，公(gong)(gong)(gong)(gong)司(si)(si)(si)收(shou)(shou)到控股(gu)(gu)股(gu)(gu)東亞寶(bao)(bao)(bao)投資質(zhi)(zhi)(zhi)(zhi)押(ya)解除通(tong)知，獲悉亞寶(bao)(bao)(bao)投資質(zhi)(zhi)(zhi)(zhi)押(ya)給山西證券股(gu)(gu)份(fen)(fen)有限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)(si)(si)的(de)(de)1365萬(wan)股(gu)(gu)無限(xian)(xian)售流通(tong)股(gu)(gu)辦理了股(gu)(gu)票質(zhi)(zhi)(zhi)(zhi)押(ya)式回購(gou)(gou)交易提前購(gou)(gou)回手續，購(gou)(gou)回交易完成后相應股(gu)(gu)份(fen)(fen)質(zhi)(zhi)(zhi)(zhi)押(ya)解除。截至本公(gong)(gong)(gong)(gong)告披露(lu)日，公(gong)(gong)(gong)(gong)司(si)(si)(si)控股(gu)(gu)股(gu)(gu)東亞寶(bao)(bao)(bao)投資持(chi)(chi)有公(gong)(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)份(fen)(fen)9430萬(wan)股(gu)(gu)，占公(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)股(gu)(gu)本的(de)(de)13.47%；本次質(zhi)(zhi)(zhi)(zhi)押(ya)解除后，亞寶(bao)(bao)(bao)投資所持(chi)(chi)有的(de)(de)公(gong)(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)份(fen)(fen)累計質(zhi)(zhi)(zhi)(zhi)押(ya)股(gu)(gu)份(fen)(fen)數為2495萬(wan)股(gu)(gu)，占其持(chi)(chi)有公(gong)(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)份(fen)(fen)總(zong)數的(de)(de)26.46%，占公(gong)(gong)(gong)(gong)司(si)(si)(si)總(zong)股(gu)(gu)本的(de)(de)3.56%。

2024年1至12月份，亞(ya)寶藥業的營業收入構成為(wei)：醫藥生(sheng)產(chan)占(zhan)比75.46%，醫藥批(pi)發占(zhan)比21.37%，其(qi)他貿易占(zhan)比1.88%，其(qi)他業務占(zhan)比1.29%。

截(jie)至發稿，亞寶(bao)藥業市值(zhi)為46億(yi)元(yuan)。

每經頭(tou)條(tiao)（nbdtoutiao）——

（記者 王曉波）

免責聲明(ming)：本(ben)文內容與數據僅(jin)供(gong)參考，不構成投資建議，使用(yong)前請核實。據此操作，風險自擔。